Effectiveness of Solution-Focused Therapy for Generalized Anxiety Disorder in Emerging Adults
1 other identifier
interventional
50
1 country
1
Brief Summary
This study will evaluate whether Solution-Focused Therapy (SFT) helps reduce symptoms of Generalized Anxiety Disorder (GAD) in emerging adults in Pakistan. Participants will first be screened to identify those with mild to moderate levels of GAD. Eligible participants will be randomly assigned to receive either SFT or be placed on a waitlist. The researcher will measure changes in anxiety symptoms before and after the intervention to determine whether SFT is effective for emerging adults with GAD in Pakistan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2026
CompletedFirst Submitted
Initial submission to the registry
August 25, 2026
CompletedFirst Posted
Study publicly available on registry
September 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 28, 2026
September 1, 2026
August 1, 2026
11 months
August 25, 2026
August 29, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Generalized Anxiety Disorder 7-item (GAD-7)
The Generalized Anxiety Disorder 7-item (GAD-7) scale assesses severity of anxiety symptoms. Total scores range from 0 to 21. Higher scores indicate more severe anxiety symptoms.
Baseline and Week 8
Depression Anxiety Stress Scales - Short Form (DASS-21)
The Depression Anxiety Stress Scales - Short Form (DASS-21) measures emotional distress. The total score ranges from 0 to 63 (combining depression, anxiety, and stress subscales). Higher scores indicate more severe emotional distress.
Baseline and Week 8
Secondary Outcomes (4)
Intolerance of Uncertainty Scale - Short Form (IUS-12)
Baseline and Week 8
Negative Problem Orientation Questionnaire (NPOQ)
Baseline and Week 8
Difficulties in Emotion Regulation Scale - Short Form (DERS-SF)
Baseline and Week 8
Brief Resilience Scale
Baseline and Week 8
Study Arms (2)
Intervention Group (Receiving Solution-Focused Therapy)
EXPERIMENTALParticipants in the intervention group will receive Solution-Focused Therapy (SFT) for mild to moderate Generalized Anxiety Disorder.
Control Group (Waitlist Control Group)
NO INTERVENTIONParticipants in the control group will not receive Solution-Focused Brief Therapy during the active trial period and will instead be assigned to a waitlist condition.
Interventions
Participants in intervention group will receive Solution-Focused Therapy. The program includes approximately 6-8 individual sessions (45-60 minutes) covering goal-setting, exception-finding, scaling questions, the miracle question, identification of existing strengths and resources, and construction of solution-focused action steps.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
International Islamic University Islamabad (IIUI)
Islamabad, 44000, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fariha Hayat, MS
International Islamic University, Islamabad
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Researcher & Principal Investigator
Study Record Dates
First Submitted
August 25, 2026
First Posted
September 1, 2026
Study Start
January 5, 2026
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
December 28, 2026
Last Updated
September 1, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share